High expression of DLL3 was tied to worsen OS in advanced GC, such as stage II, HR 2.37 (1.23–4.55), p = 0.008 and stage III, HR 1.56 (1.12–2.19), p = 0.009. This evidence concerns the gene DLL3 and gastric cancer.